Clinical trial
A 12-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Related Mechanism of Sulforaphane in Treatment of Autism Spectrum Disorder
NCT02879110 is registered in ClinicalTrials.gov with Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Related Mechanism of Sulforaphane in Treatment of Autism Spectrum Disorder
- Lead sponsor
- Central South University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- July 31, 2019
- Enrollment
- 110 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.